Comparative Study Serum and Cutaneous Total Bilirubin among Newborns with Hyperbilirubinemia in Khartoum State

  • Isam Ahmed Sadik

الملخص

The standard methods used in measuring serum bilirubin require blood specimens taken by heel pricks or intravenous blood sampling but transcutanse bilirubin is a new method for measuring bilirubin in neonate. So this study was conducted to compare the estimates of serum bilirubin using a recently introduced device called (MBJ20), which is TransCutaneous Bilirubinometer (TCB) index with the standard direct spectrophotometric measurement of Total Serum Bilirubin (TSB). This cross-sectional study was conducted in neonatal intensive care unit at Soba University Hospital, where one hundred and fifty three, newborns with hyperbilibrubina were enrolled. Both TSB and, TCB readings were evaluated.

According to the date of jaundice onset 91.9% developed jaundice during period of 2-7 days; 5.9% in the first day and 2.6% after a week. TSB level among jaundiced neonates less than 12 mg/dL was found in (29.4%), 12 – 2 mg/dL were detected in (67.9%), and More than 20 mg/dL was recorded in (2.6%). On the other hand TCB level was less than 12 mg/dL found in (20.9%), 12 – 2 mg/dL was detected in (77.1%) and more than 20 mg/dL cited for (1.9%). At P≤0.05 there were no significant differences in TSB and TCB before phototherapy with Mean (13.40±2.83, 13.49±3.00) mg/dL for TSB and TCB respectively (P value .539). And after photo therapy Mean of TSB and TCB index were (13.00 ±4.40, 13.06±2.57) mg/dL respectively (P value 0.769). Neonatal birth weight showed extremely low birth (2.6%), low birth weight in (54.9%), normal weight (37.3%) and Macrosomic (5.2%). The Gestational age of jaundiced neonates showed pre-term (48.4%), term (49%) and Post-term (2.6%). The study revealed that TCB was an accurate method, as TSB before and after phototherapy. No difference when TCB was used for measuring TSB in term or preterm babies. So TCB device could be used in every Nursery as reliable.

المراجع

1. Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. InSeminars in fetal and neonatal Medicine 2008 Aug 31 (Vol. 13, No. 4, pp. 265-271). WB Saunders.
2. Wong CM, Van Dijk PJ, Laing IA. A comparison of transcutaneous bilirubinometers: SpectRx BiliCheck versus Minolta AirShields. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2002 Sep 1;87(2):F137-40.
3. Facchini FP, Mezzacappa MA, Rosa IR, Mezzacappa Filho F, Aranha Netto A, Marba ST. Follow-up of neonatal jaundice in term and late premature newborns. Jornal de pediatria. 2007 Aug;83(4):313-8.
4. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. The Journal of pediatrics. 2002 Apr 30;140(4):396-403.
5. Chung M, Kulig J, O'Brien R, Sege R, Glicken S, Maisels MJ, Lau J. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004 Jul 1;114(1):e130-53.
6. Kolman KB, Mathieson KM, Frias C. A comparison of transcutaneous and total serum bilirubin in newborn Hispanic infants at 35 or more weeks of gestation. The Journal of the American Board of Family Medicine. 2007 May 1;20(3):266-71.
7. Ruud Hansen TW. Phototherapy for neonatal jaundice, therapeutic effects on more than one level? Semin Perinatol. 2010; 34(3):231-4.
8. Robert M, Kliegman MD, Bonita MD, Stanton MD, Joseph ST, Geme Nina Schor et al. Behrman, MD. Nelson Textbook of Pediatrics, 19th Ed, 2010, 753.
9. Panburana J, Boonkasidach S, Rearkyai S. Accuracy of transcutaneous bilirubinometry compare to total serum bilirubin measurementBangkok, Thailand. Feb; 93 Suppl 2010; 2:S81-6.
10. Tan KL, Dong F. Transcutaneous bilirubinometry during and after phototherapy. Acta Paediatr 2003; 92:327-331.
منشور
2017-10-01